U.S. Software Stock News

Progressive (PGR) has drawn fresh attention after its stock gained 2.03% to close at US$204.20, outperforming major indices as traders positioned ahead of an earnings report that is expected to show lower EPS but higher revenue. See our latest analysis for Progressive. At around US$203.11 today, the recent 2.03% daily gain sits against a year to date share price return that is down 4.25%. The three year total shareholder return of 70.99% and five year total shareholder return of 146.08% point...

Kaspi.kz’s Extraordinary General Meeting on 11 June 2026 approved a first‑quarter 2026 dividend of KZT 850 per common share, with payments commencing 11 June 2026 to shareholders of record on 10 June 2026. The meeting also appointed a new three‑member Counting commission with unlimited terms, signalling an emphasis on oversight of shareholder voting and corporate decisions. We’ll now examine how this newly declared KZT 850 dividend shapes Kaspi.kz’s investment narrative around capital...

Recently, NETSTREIT was upgraded to a Zacks Rank #2 (Buy), reflecting increased optimism among analysts about its earnings outlook based on higher estimates. This shift in analyst sentiment highlights how changes in earnings expectations alone can materially influence how investors view a net-lease REIT like NETSTREIT. Now we will explore how this earnings-driven Zacks upgrade shapes NETSTREIT's existing investment narrative built around necessity-based retail demand. Find 44 companies with...

Recently, Zacks assigned Nexa Resources a Rank #1 (Strong Buy) after analysts raised full-year earnings estimates, signaling a stronger earnings outlook based on updated forecasts. This upgrade highlights a sharp improvement in analyst sentiment toward Nexa’s fundamentals, especially relative to many other Basic Materials names. Next, we’ll examine how this improved analyst outlook and higher earnings estimates may influence Nexa Resources’ existing investment narrative. The latest GPUs need...

Bolt, Pony.ai, and Stellantis recently launched an autonomous mobility pilot in Luxembourg to test Pony.ai’s seventh-generation robotaxi on Stellantis’ L4-Ready midsize vans using Bolt’s ride-hailing platform. The project highlights Luxembourg’s supportive regulatory framework as a proving ground for validating Pony.ai’s autonomous driving technology and readiness for future European deployment. Next, we will examine how this European pilot, especially testing seventh-generation autonomous...

We wouldn't blame Expedia Group, Inc. ( NASDAQ:EXPE ) shareholders if they were a little worried about the fact that...

Ooma, Inc.'s ( NYSE:OOMA ) earnings announcement last week was disappointing for investors, despite the decent profit...

Sea (NYSE:SE) is back in focus after reporting 38% year over year revenue growth while simultaneously reinvesting in fulfillment, instant delivery, and other ecosystem services, and cutting several hundred Shopee developer roles globally. See our latest analysis for Sea. The latest quarter of 38% year over year revenue growth and reinvestment in Shopee and Monee is landing against a weaker share price backdrop. The stock is at US$82.94, the year to date share price return is down 36.92%, the...

Recently, Healthcare Services Group was highlighted with a Zacks Rank of #2 (Buy) after analysts raised their full-year earnings estimate by 7.4%, reflecting an upgraded outlook for the company. This improving analyst sentiment comes as Healthcare Services Group has outperformed the broader Business Services sector so far this year, suggesting its business model is attracting increasing investor attention. We’ll now examine how this upgraded earnings outlook and stronger analyst sentiment...

Valmont Industries (VMI) is drawing fresh attention as government funded infrastructure programs and global water management pressures support its order backlog, while the stock’s richer valuation and recent insider selling give investors more to weigh. See our latest analysis for Valmont Industries. Recent price action has been strong, with a 33.61% 3 month share price return and a 71.22% 1 year total shareholder return. This suggests momentum has been building as investors respond to solid...

Recent share performance and business snapshot Columbia Financial (CLBK) has drawn investor attention after a period of solid stock performance, with the share price at $20.70 and total return around 49% over the past year. For context, the bank holding company reports annual revenue of about $259.2 million and net income of $55.97 million, with both revenue and profit showing positive annual growth rates based on the latest figures provided. The stock’s gains of about 6% over the past month...

Earlier in June 2026, Sonida Senior Living filed a shelf registration for about US$613.36 million of common stock, covering up to 17,109,184 shares, and appointed veteran hospitality executive Anton Nikodemus as its first Chief Operating Officer. The combination of a large potential equity program and a COO focused on operational performance and SPIN, Sonida’s data-driven platform, could shape how the company funds and manages its expanded senior housing portfolio. Now, we’ll consider how...

Molina Healthcare (MOH) is back on investor radar after its Illinois subsidiary secured a HealthChoice Illinois Medicaid Managed Care contract, along with improving Q1 2026 margins and fresh attention from recent analyst actions. See our latest analysis for Molina Healthcare. The recent 36.7% 90 day share price return and 8.3% 30 day share price return suggest momentum has picked up around the Illinois Medicaid contract win, Q1 2026 margin improvement and renewed analyst attention, even...

Grindr (GRND) is back in focus after its partnership with Warner Records and Madonna, which featured a live streamed performance inside the app and broader in-app experiences aimed at deepening user engagement. See our latest analysis for Grindr. At a share price of $11.64, Grindr’s 7 day share price return of 6.79% and 1 day move of 1.48% sit against a 30 day share price return that is down 13.13% and a 1 year total shareholder return that is down 49.41%. The 3 year total shareholder return...

Investors may be considering whether W.W. Grainger at around US$1,315 per share still offers value, or if most of the opportunity is already priced in. The stock has posted returns of 1.2% over the last week, 3.4% over the last month, 31.1% year to date and 24.7% over the past year, which can change how investors think about both its potential and its risks. Recent coverage has focused on W.W. Grainger's role in industrial distribution and how it is positioning its operations and customer...

Recently, General Dynamics’ board declared a regular quarterly dividend of US$1.59 per share, payable on August 7, 2026, to shareholders of record on July 2, 2026, while the company also reported double-digit growth in revenue and operating earnings across all major segments. At the same time, a Jefferies rating upgrade highlighting accelerating U.S. submarine demand and a multi-billion-dollar Columbia-class contract have sharpened investor attention on the Marine Systems division as a key...

Recent performance and what it might mean for investors Republic Bancorp (RBCA.A) has drawn attention after a period of solid share price performance, with the stock up 1.0% over the past day, 3.7% over the past week and 16.1% over the past month. Over the past 3 months, the stock has returned 26.4%, with a 31.9% total return over the past year and very large gains over 3 and 5 years. That backdrop sets the stage for a closer look at how current fundamentals line up with recent market...

We wouldn't blame NRC Health ( NASDAQ:NRC ) shareholders if they were a little worried about the fact that Michael...

In recent days, Iridium Communications has come under pressure as insider share sales and ARK Investment Management’s sizeable divestment heightened concerns about its valuation and the implications of its planned Aireon stake acquisition financing. This combination of insider selling, institutional repositioning, and added balance sheet risk from the Aireon deal is prompting investors to reassess how resilient Iridium’s long-term growth and capital return ambitions really are. We’ll now...

3M Company recently added Jennifer W. Rumsey, Chair and CEO of Cummins, to its Board of Directors, also appointing her to the Science, Technology and Sustainability Committee as of June 5, 2026. Her engineering background and experience leading a global industrial technology company may strengthen 3M’s oversight of innovation, operations, and long-term sustainability priorities. We’ll now examine how the resolution of major litigation and renewed operational focus may influence 3M’s existing...

American International Group (AIG) stock came under pressure after the company announced a CEO succession plan, which many investors interpreted as reducing the likelihood of a future Chubb acquisition and the associated deal premium. See our latest analysis for American International Group. At a share price of US$75.74, AIG has seen its 1-day share price return of 0.56% and year to date share price decline of 10.12% sit against a 5-year total shareholder return of 79.94%. This points to...

Investor Day spotlight on EnerSys stock EnerSys (ENS) has drawn fresh attention after its Investor Day, where leadership outlined a repositioning toward data centers, aerospace, and defense, anchored by new products such as the DataSafe Noir lithium ion system. See our latest analysis for EnerSys. EnerSys shares have pulled back slightly in the very short term, with a 30 day share price return of down 5.37%. However, the 90 day share price return of 38.47% and 1 year total shareholder return...

Popular, Inc. previously declared a monthly cash dividend of US$0.132813 per share on its 6.375% Non-Cumulative Monthly Income Preferred Stock, 2003 Series A, payable on June 30, 2026, alongside a US$0.127604 monthly distribution on its 6.125% Cumulative Monthly Income Trust Preferred Securities payable on July 1, 2026. These distributions, coupled with recent positive momentum indicators and upward earnings estimate revisions, highlight how Popular is pairing income-focused capital returns...

Earlier in June 2026, Alvotech reported that the FDA accepted its Biologics License Application for AVT16, a proposed interchangeable biosimilar to Entyvio for intravenous use, while also resubmitting BLAs for AVT05 and AVT06 after enhancing its Reykjavik manufacturing facility and addressing regulatory observations. These regulatory milestones highlight Alvotech’s expanding biosimilar pipeline in immunology and ophthalmology and indicate progress in strengthening its quality systems under...